Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage

Author(s): Kim GH, Kellner CP, Hahn DK, Desantis BM, Musabbir M, et al.

Abstract

Object:Despite efforts to elucidate both the molecular mechanism and the clinical predictors of vasospasm after aneurysmal subarachnoid hemorrhage (ASAH), its pathogenesis remains unclear. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that has been firmly implicated in the pathophysiology of vasospasm and in neural tissue injury following focal ischemia in both animal models and human studies. The authors hypothesized that MCP-1 would be found in increased concentrations in the blood and cerebrospinal fluid (CSF) of patients with ASAH and would correlate with both outcome and the occurrence of vasospasm.

Methods:Seventy-seven patients who presented with ASAH were prospectively enrolled in this study between July 2001 and May 2002. Using an enzyme-linked immunosorbent assay, MCP-1 levels were measured in serum daily and in CSF when available. The mean serum and CSF MCP-1 concentrations were calculated for each patient throughout the entire hospital stay. Neurological outcome was evaluated at discharge or 14 days posthemorrhage using the modified Rankin Scale. Vasospasm was evaluated on angiography.

Results:The serum MCP-1 concentrations correlated with negative outcome such that a 10% increase in concentration predicted a 25% increase in the probability of a poor outcome, whereas the serum MCP-1 levels did not correlate with vasospasm. Concentrations of MCP-1 in the CSF, however, proved to be significantly higher in patients with angiographically demonstrated vasospasm.

Conclusions:These findings suggest a role for MCP-1 in neurological injury and imply that it may act as a biomarker of poor outcome in the serum and of vasospasm in the CSF.

Similar Articles

Cerebral vasospasm following aneurysmal subarachnoid hemorrhage

Author(s): Kassell NF, Sasaki T, Colohan AR, Nazar G

Altered patterns of gene expression in response to myocardial infarction

Author(s): Stanton LW, Garrard LJ, Damm D, Garrick BL, Lam A, et al.

Genomics of human intracranial aneurysm wall

Author(s): Shi C, Awad IA, Jafari N, Lin S, Du P, et al.

Bioconductor: open software development for computational biology and bioinformatics

Author(s): Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al.

TM4 microarray software suite

Author(s): Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al.

Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats

Author(s): Suzuki H, Kanamaru K, Tsunoda H, Inada H, Kuroki M, et al.

Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat

Author(s): Vikman P, Beg S, Khurana TS, Hansen-Schwartz J, Edvinsson L

Gene expression in a canine basilar artery vasospasm model: a genome-wide network-based analysis

Author(s): Sasahara A, Kasuya H, Krischek B, Tajima A, Onda H, et al.

Global quantification of mammalian gene expression control

Author(s): Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, et al.

Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage

Author(s): Borel CO, McKee A, Parra A, Haglund MM, Solan A, et al.

Oxidative stress activates STAT1 in basilar arteries after subarachnoid hemorrhage

Author(s): Osuka K, Watanabe Y, Usuda N, Atsuzawa K, Wakabayashi T, et al.

Cerebral artery spasm

Author(s): Hughes JT, Schianchi PM

Stroke: anatomy of a catastrophic event

Author(s): Zhang J, Lewis A, Bernanke D, Zubkov A, Clower B

Neuroprotection by osteopontin in stroke

Author(s): Meller R, Stevens SL, Minami M, Cameron JA, King S, et al.

Expression, roles, receptors, and regulation of osteopontin in the kidney

Author(s): Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, et al.

Apoptosis of endothelial cells in vessels affected by cerebral vasospasm

Author(s): Zubkov AY, Ogihara K, Bernanke DH, Parent AD, Zhang J

Morphological changes of cerebral arteries in a canine double hemorrhage model

Author(s): Zubkov AY, Tibbs RE, Clower B, Ogihara K, Aoki K, et al.

Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage

Author(s): Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M

Barrier disruption in the major cerebral arteries during the acute stage after experimental subarachnoid hemorrhage

Author(s): Sasaki T, Kassell NF, Zuccarello M, Nakagomi T, Fijiwara S, et al.

Immune complexes and complement activation following rupture of intracranial saccular aneurysms

Author(s): Ostergaard JR, Kristensen BO, Svehag SE, Teisner B, Miletic T